Clinical trial
Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus…
NCT00384891 · Medical Enterprises Europe B.V., Industry · Terminated
Key facts
| NCT number | NCT00384891 |
|---|---|
| Title | Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer |
| Official title | A Randomized Controlled Study Comparing Adjuvant Hyperthermia Treatment in Conjunction With Mitomycin C Versus BCG Immunotherapy (BCG) Adjuvant Treatment in Patients With Superficial Transitional Cell Carcinoma of the Bladder (STCCB) |
| Lead sponsor | Medical Enterprises Europe B.V., Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urinary Bladder Cancer, Malignant Tumor of Urinary Bladder, Urologic Diseases, Urologic Neoplasms, Neoplasms, Neoplasms by Site |
| Intervention type | Device, Drug |
| Interventions | Synergo + MMC, Bacillus Calmette-Guérin |
| Enrollment | 190 |
| Start date | Feb 1, 2002 |
| Primary completion | Dec 1, 2013 |
| Completion | Dec 1, 2013 |
| First posted | Oct 6, 2006 |
| Last update posted | Oct 7, 2014 |
| Countries | Austria, Israel, Italy, Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: